Search

everythinglearnresearchcommunity

for

Search:↓

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Propylene glycol and ethanol increase finasteride skin absorption, sodium lauryl sulfate doesn't.

Future research should focus on making bioengineered skin that completely restores all skin functions.

Dermal papilla cells help wounds heal better and can potentially grow new hair.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Using tissue expanders with galeotomies for post-burn alopecia is faster and has fewer complications.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

No treatment fully prevents hair loss from chemotherapy yet.

Researchers found a new way to create hair-growing structures in the lab that can grow hair when put into mice.

Advancements in tissue engineering show promise for hair follicle regeneration to treat hair loss.

Understanding hair follicles through various models can help develop new treatments for hair disorders.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Greying hairs may be protected from alopecia areata.

Stem cells could improve hair growth and new treatments for baldness are being researched.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

People with alopecia areata may be more likely to have a certain type of hearing loss.

Targeting FGFR-1 with antisense oligonucleotides may help treat baldness by increasing hair follicle activity.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

The new method can create hair follicle-like structures but not complete hair with roots and shafts, needing more improvement.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.